Phase 3 Study Assessing Lot-to-lot Consistency of RSVPreF3 Vaccine and its Immune Response, Safety, and Reactogenicity When Co-administered with FLU-D-QIV.
Nnenna ChimeBruno AnspachVishal JainOuti LaajalahtiThierry OllingerDeborah YapleeJoon Hyung KimPublished in: The Journal of infectious diseases (2024)
NCT05045144; EudraCT, 2021-000357-26.